Health> Vol.5 No.12, December 2013

Manganese toxicity in the central nervous system: Decreeing of catecholamine in rat’s brains

DownloadDownload as PDF (Size:158KB)  HTML    PP. 2146-2149  

ABSTRACT

Manganese is an essential metal in human that functions in many enzymes. In contrast excessive exposure to Mn results in neurotoxicity. Accumulation of manganese damages central nervous system and causes Parkinson disease like syndrome called manganism. Mn neurotoxicity has been suggested to involve an imbalance in catecholamine neurotransmitters. It hypothesized that Mn can obstruct catecholamine synthesis pathway by inhibition of Tyrosine hydroxylase. Previous studies demonstrated that chronic and acute dose of Mn has different possible effects on catecholamine synthesis. It’s assumed that an acute dose of manganese can kill dopaminergic cells. Therefore, we focused the effect of Mn in catecholamine concentration on the rat’s brain by MnCl2 injection intraperitoneally and analyzed their brains after the time interval. This study used different acute doses in short time courses and different chronic doses at different exposing times to investigate which of them (exposing dose or time) is more important in Mn toxic effect. Measurement of catecholamine concentration performed by fluorescence assay in acidic and oxidant environment.

 

Cite this paper

Babadi, V. , Sadeghi, L. , Amraie, E. , Rezaei, M. , Malekirad, A. and Nejad, M. (2013) Manganese toxicity in the central nervous system: Decreeing of catecholamine in rat’s brains. Health, 5, 2146-2149. doi: 10.4236/health.2013.512292.

References

[1] Holleman, A.F., Wiberg, E. and Wiberg, N. (1995) Lehrbuch der anorganischen Chemie. Walter de Gruyter.
[2] Romani, A. (2007) Magnesium homeostasis in mammalian cells. Frontiers in Bioscience, 12, 308-331.
http://dx.doi.org/10.2741/2066
[3] Orten, J.M. and Neuhaus, O.W. (1975) Human biochemistry. CV Mosby.
[4] Aschner, M. and Aschner, J.L. (1991) Manganese neurotoxicity: Cellular effects and blood-brain barrier transport. Neuroscience & Biobehavioral Reviews, 15, 333-340.
http://dx.doi.org/10.1016/S0149-7634(05)80026-0
[5] Guilarte, T.R. (2010) Manganese and Parkinson’s disease: A critical review and new findings. Environmental Health Perspectives, 118, 1071.
http://dx.doi.org/10.1289/ehp.0901748
[6] Blecharz-Klin, K., et al. (2012) Effect of intranasal manganese administration on neurotransmission and spatial learning in rats. Toxicology and Applied Pharmacology, 265, 1-9. http://dx.doi.org/10.1016/j.taap.2012.09.015
[7] Stokinger, H. (1981) The metals. In: Patty’s Industrial Hygiene and Toxicology, 2, 1749-1769.
[8] Deng, Q., et al. (2013) Interaction of occupational manganese exposure and alcohol drinking aggravates the increase of liver enzyme concentrations from a cross-sectional study in China. Environmental Health, 12, 30.
http://dx.doi.org/10.1186/1476-069X-12-30
[9] Zhang, D., et al. (2011) Effects of manganese on tyrosine hydroxylase (TH) activity and TH-phosphorylation in a dopaminergic neural cell line. Toxicology and Applied Pharmacology, 254, 65-71.
http://dx.doi.org/10.1016/j.taap.2010.03.023
[10] Sidoryk-Wegrzynowicz, M. and Aschner, M. (2013) Manganese toxicity in the central nervous system: The glutamine/glutamate-gamma-aminobutyric acid cycle. Journal of Internal Medicine, 273, 466-477.
http://dx.doi.org/10.1111/joim.12040
[11] Barceloux, D.G. (1999) Manganese. Journal of Toxicology—Clinical Toxicology, 37, 293-307.
http://dx.doi.org/10.1081/CLT-100102427
[12] Lee, J.-W. (2000) Manganese intoxication. Archives of Neurology, 57, 597.
http://dx.doi.org/10.1001/archneur.57.4.597
[13] Lucchini, R., et al. (2012) Neurological impacts from inhalation of pollutants and the nose-brain connection. Neurotoxicology, 33, 838-841.
http://dx.doi.org/10.1016/j.neuro.2011.12.001
[14] Aschner, M., et al. (2009) Manganese and its role in Parkinson’s disease: From transport to neuropathology. Neuromolecular medicine, 11, 252-266.
http://dx.doi.org/10.1007/s12017-009-8083-0
[15] Dodd, C., Bloomquist, J. and Klein, B. (2012) Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-exposed C57BL/6 mice. Human & Experimental Toxicology, 32, 865-880.
[16] Racette, B.A., et al. (2012) Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology, 33, 881-886. http://dx.doi.org/10.1016/j.neuro.2011.12.010
[17] Yin, Z., et al. (2008) Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Research, 1203, 1-11.
http://dx.doi.org/10.1016/j.brainres.2008.01.079
[18] Gavin, C.E., Gunter, K.K. and Gunter, T.E. (1990) Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochemical Journal, 266, 329-334.
[19] Guilarte, T.R., et al. (2008) Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced Parkinsonism. Journal of Neurochemistry, 107, 1236-1247.
http://dx.doi.org/10.1111/j.1471-4159.2008.05695.x
[20] Erikson, K.M., et al. (2008) Duration of airborne-manganese exposure in rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Neurotoxicology, 29, 377-385.
http://dx.doi.org/10.1016/j.neuro.2007.12.007
[21] Aschner, M., Lukey, B. and Tremblay, A. (2006) The Manganese health research program (MHRP): Status report and future research needs and directions. Neurotoxicology, 27, 733-736.
http://dx.doi.org/10.1016/j.neuro.2005.10.005
[22] Zhang, D., et al. (2007) Protein kinase cδ negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2a activity in dopaminergic neurons. The Journal of Neuroscience, 27, 5349-5362.
http://dx.doi.org/10.1523/JNEUROSCI.4107-06.2007
[23] Takeda, A., et al. (1998) Manganese transport in the neural circuit of rat CNS. Brain research bulletin, 45, 149-152. http://dx.doi.org/10.1016/S0361-9230(97)00330-4
[24] Latchoumycandane, C., et al. (2005) Protein kinase Cδ is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. Journal of Pharmacology and Experimental Therapeutics, 313, 46-55.
http://dx.doi.org/10.1124/jpet.104.078469
[25] Felice, L.J., Felice, J.D. and Kissinger, P.T. (1978) Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. Journal of neurochemistry, 31, 1461-1465.
http://dx.doi.org/10.1111/j.1471-4159.1978.tb06573.x
[26] Feller, D.J. and O’Dell, B.L. (1980) Dopamine and norepinephrine in discrete areas of the copper-deficient rat brain. Journal of Neurochemistry, 34, 1259-1263.
http://dx.doi.org/10.1111/j.1471-4159.1980.tb09968.x
[27] Anton, A.H. and Sayre, D.F. (1964) The distribution of dopamine and dopa in various animals and a method for their determination in diverse biological material. Journal of Pharmacology and Experimental Therapeutics, 145, 326-336.

  
comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.